Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 30, 2025 08:36 ET | Source: Bleichmar Fonti & Auld

REPL INVESTORS: Replimune Group, Inc. (NASDAQ:REPL) Investors may have been Affected by Fraud – Contact BFA Law by September 22 about Potentially Recovering Losses

Replimune Group, Inc. investors that lost money are notified to contact BFA Law before the September 22, 2025 securities fraud class action deadline.
July 28, 2025 08:36 ET | Source: Bleichmar Fonti & Auld

REPL LAWSUIT: Replimune Group, Inc. Sued for Fraud after FDA Response Letter – Contact BFA Law by September 22 Court Deadline (NASDAQ:REPL)

Replimune Group, Inc. investors that lost money are notified to contact BFA Law before the September 22, 2025 securities fraud class action deadline.
July 26, 2025 07:08 ET | Source: Bleichmar Fonti & Auld

REPL CLASS ACTION ALERT: FDA Response Letter Leads to Replimune Group, Inc. Class Action – Investors are Notified to Contact BFA Law by September 22 Deadline

Replimune Group, Inc. investors that lost money are notified to contact BFA Law about its ongoing securities fraud class action investigation.
July 24, 2025 08:07 ET | Source: Bleichmar Fonti & Auld

REPL STOCK NEWS: Replimune Group, Inc. (NASDAQ:REPL) is Facing a Securities Fraud Investigation – Investors with Losses are Notified to Contact BFA Law

Replimune Group, Inc. investors that lost money are notified to contact BFA Law about its ongoing securities fraud class action investigation.
July 22, 2025 11:03 ET | Source: Block & Leviton LLP

BREAKING: Replimune Group, Inc. Shares Drop 70%; Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

Block & Leviton is investigating Replimune Group, Inc. (Nasdaq: REPL) for potential securities law violations. Investors should contact the firm.